Return
Resolvin D1 alleviates periodontitis by promoting FPR2-dependent macrophage pro-resolving polarization and efferocytosis
X
Z
R
S
J
Y
J
Z
G
F
李
J
DOI:10.1016/j.jare.2026.08.001.png)
Abstract
En 中文
• Human periodontitis exhibits a resolution-deficient immune landscape marked by impaired efferocytosis and reduced RvD1 biosynthesis. • FPR2 is required for RvD1-mediated periodontal protection, as demonstrated in myeloid-specific Fpr2 knockout models. • Single-cell profiling reveals that RvD1 reprograms monocyte–macrophage states toward a pro-resolving phenotype in alveolar bone. • RvD1 promotes inflammatory resolution by inhibiting the p38 MAPK–ADAM17 axis and preserving CD14-dependent efferocytosis. • RvD1 restores macrophage efferocytotic function, supporting its therapeutic potential for periodontitis and chronic inflammatory diseases.
Keywords:
Periodontitis
Resolvin D1
Efferocytosis
Macrophage
Formyl peptide receptor 2
Inflammation resolution
Journal
IF:
13
Papers:
2.8K
Citations:
1.4W
